| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.0042 | 1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.0041 | 1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.00069 | 1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00059 | 1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |